Id |
Subject |
Object |
Predicate |
Lexical cue |
tao:has_database_id |
tao:has_standard_notation |
T1 |
0-9 |
Mutation |
denotes |
Mutations |
|
|
T10 |
17-27 |
Species |
denotes |
SARS-CoV-2 |
Tax:2697049 |
|
T17 |
28-33 |
Gene |
denotes |
spike |
Gene:43740568 |
|
T2 |
34-37 |
Biological |
denotes |
RBD |
|
|
T47 |
58-66 |
PositiveRegulation |
denotes |
stronger |
|
|
T6 |
67-71 |
Gene |
denotes |
ACE2 |
Gene:59272 |
|
T43 |
72-79 |
Bind |
denotes |
binding |
|
|
T48 |
84-88 |
NegativeRegulation |
denotes |
poor |
|
|
T49 |
94-102 |
Species |
denotes |
SARS-CoV |
Tax:2697049 |
|
T29 |
103-107 |
Biological |
denotes |
mAbs |
MESH:D000911 |
|
T40 |
114-128 |
Interrupt |
denotes |
neutralization |
|
|
T22 |
131-178 |
Species |
denotes |
Severe acute respiratory syndrome coronavirus 2 |
Tax:2697049 |
|
T11 |
180-190 |
Species |
denotes |
SARS-CoV-2 |
Tax:2697049 |
|
T26 |
206-230 |
Disease |
denotes |
coronavirus disease 2019 |
MESH:D000086382 |
|
T25 |
232-240 |
Disease |
denotes |
COVID-19 |
MESH:D000086382 |
|
T32 |
254-270 |
Species |
denotes |
beta coronavirus |
Tax:694002 |
|
T12 |
272-282 |
Species |
denotes |
SARS-CoV-2 |
Tax:2697049 |
|
T18 |
288-306 |
Gene |
denotes |
spike glycoprotein |
Gene:43740568 |
|
T33 |
310-318 |
Bind |
denotes |
interact |
|
|
T35 |
324-328 |
Species |
denotes |
host |
|
|
T20 |
329-360 |
Gene |
denotes |
angiotensin-converting enzyme 2 |
Gene:59272 |
|
T7 |
362-366 |
Gene |
denotes |
ACE2 |
Gene:59272 |
|
T13 |
417-427 |
Species |
denotes |
SARS-CoV-2 |
Tax:2697049 |
|
T19 |
448-453 |
Gene |
denotes |
spike |
Gene:43740568 |
|
T8 |
454-458 |
Gene |
denotes |
ACE2 |
Gene:59272 |
|
T44 |
459-466 |
Bind |
denotes |
binding |
|
|
T41 |
484-498 |
Interrupt |
denotes |
neutralization |
|
|
T54 |
507-515 |
Species |
denotes |
SARS-CoV |
Tax:2697049 |
|
T27 |
516-537 |
Biological |
denotes |
monoclonal antibodies |
MESH:D000911 |
|
T28 |
539-543 |
Biological |
denotes |
mAbs |
MESH:D000911 |
|
T21 |
564-586 |
Mutation |
denotes |
Val-to-Lys417 mutation |
|
p.V417K |
T31 |
594-618 |
Biological |
denotes |
receptor-binding domains |
|
|
T3 |
620-623 |
Biological |
denotes |
RBD |
|
|
T14 |
628-638 |
Species |
denotes |
SARS-CoV-2 |
Tax:2697049 |
|
T58 |
646-657 |
PositiveRegulation |
denotes |
established |
|
|
T9 |
708-712 |
Gene |
denotes |
ACE2 |
Gene:59272 |
|
T46 |
713-720 |
Bind |
denotes |
binding |
|
|
T23 |
722-748 |
Mutation |
denotes |
Pro-to-Ala475 substitution |
|
p.P475A |
T24 |
753-769 |
Mutation |
denotes |
Gly482 insertion |
|
p.G482 |
T36 |
777-791 |
Biological |
denotes |
AGSTPCNGV-loop |
|
|
T4 |
795-798 |
Biological |
denotes |
RBD |
|
|
T38 |
808-815 |
NegativeRegulation |
denotes |
hinders |
|
|
T39 |
816-830 |
Interrupt |
denotes |
neutralization |
|
|
T15 |
834-844 |
Species |
denotes |
SARS-CoV-2 |
Tax:2697049 |
|
T57 |
853-861 |
Species |
denotes |
SARS-CoV |
Tax:2697049 |
|
T30 |
862-866 |
Biological |
denotes |
mAbs |
MESH:D000911 |
|
T59 |
906-943 |
Condition |
denotes |
structurally conserved conformational |
|
|
T42 |
944-952 |
Biological |
denotes |
epitopes |
MESH:D000939 |
|
T5 |
956-959 |
Biological |
denotes |
RBD |
|
|
T16 |
1099-1109 |
Species |
denotes |
SARS-CoV-2 |
Tax:2697049 |
|
R1 |
T28 |
T27 |
abbreviation |
mAbs,monoclonal antibodies |
R10 |
T35 |
T20 |
of_a |
host,angiotensin-converting enzyme 2 |
R14 |
T31 |
T21 |
of_a |
receptor-binding domains,Val-to-Lys417 mutation |
R15 |
T36 |
T24 |
of_a |
AGSTPCNGV-loop,Gly482 insertion |
R16 |
T4 |
T24 |
of_a |
RBD,Gly482 insertion |
R17 |
T14 |
T31 |
of_a |
SARS-CoV-2,receptor-binding domains |
R18 |
T30 |
T39 |
of_a |
mAbs,neutralization |
R19 |
T23 |
T38 |
is_a |
Pro-to-Ala475 substitution,hinders |
R2 |
T3 |
T31 |
abbreviation |
RBD,receptor-binding domains |
R20 |
T24 |
T38 |
is_a |
Gly482 insertion,hinders |
R21 |
T38 |
T39 |
is_a |
hinders,neutralization |
R22 |
T15 |
T39 |
to |
SARS-CoV-2,neutralization |
R23 |
T10 |
T17 |
of_a |
SARS-CoV-2,spike |
R24 |
T17 |
T1 |
of_a |
spike,Mutations |
R25 |
T17 |
T2 |
of_a |
spike,RBD |
R26 |
T1 |
T47 |
is_a |
Mutations,stronger |
R27 |
T47 |
T43 |
is_a |
stronger,binding |
R28 |
T6 |
T43 |
to |
ACE2,binding |
R29 |
T29 |
T40 |
is_a |
mAbs,neutralization |
R3 |
T11 |
T22 |
abbreviation |
SARS-CoV-2,Severe acute respiratory syndrome coronavirus 2 |
R31 |
T1 |
T48 |
is_a |
Mutations,poor |
R32 |
T48 |
T40 |
is_a |
poor,neutralization |
R33 |
T19 |
T44 |
is_a |
spike,binding |
R34 |
T8 |
T44 |
abbreviation |
ACE2,binding |
R35 |
T27 |
T41 |
is_a |
monoclonal antibodies,neutralization |
R37 |
T31 |
T46 |
is_a |
receptor-binding domains,binding |
R38 |
T9 |
T46 |
to |
ACE2,binding |
R39 |
T21 |
T58 |
is_a |
Val-to-Lys417 mutation,established |
R4 |
T25 |
T26 |
abbreviation |
COVID-19,coronavirus disease 2019 |
R40 |
T58 |
T46 |
is_a |
established,binding |
R41 |
T57 |
T30 |
against |
SARS-CoV,mAbs |
R42 |
T49 |
T29 |
against |
SARS-CoV,mAbs |
R43 |
T54 |
T27 |
against |
SARS-CoV,monoclonal antibodies |
R44 |
T5 |
T42 |
of_a |
RBD,epitopes |
R45 |
T42 |
T59 |
has_status |
epitopes,structurally conserved conformational |
R5 |
T22 |
T26 |
cause_of |
Severe acute respiratory syndrome coronavirus 2,coronavirus disease 2019 |
R6 |
T7 |
T20 |
abbreviation |
ACE2,angiotensin-converting enzyme 2 |
R7 |
T18 |
T33 |
is_a |
spike glycoprotein,interact |
R8 |
T20 |
T33 |
to |
angiotensin-converting enzyme 2,interact |
R9 |
T12 |
T18 |
of_a |
SARS-CoV-2,spike glycoprotein |